A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”-Reference-Cited by-同舟云学术

A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”

Published:2021-12 Issue: Volume:Volume 14 Page:2115-2134
ISSN:1179-1578
Container-title:Psychology Research and Behavior Management
language:en
Short-container-title:PRBM

Author:

Blum Kenneth^ORCID,Steinberg Bruce,Gondré-Lewis Marjorie C,Baron David,Modestino Edward J^ORCID,Badgaiyan Rajendra D^ORCID,Downs B William,Bagchi Debasis,Brewer Raymond,McLaughlin Thomas^ORCID,Bowirrat Abdalla^ORCID,Gold Mark

Publisher

Informa UK Limited

Subject

Psychiatry and Mental health,General Psychology

Reference135 articles.

1. SAMHSA. Available from: SAMHSA.gov/data/report/results-2013-national-survey-drug-use-and-health-detailed-tables. Accessed November 24, 2021

2. National Institutes on Drug Abuse, Substance Abuse and Mental Health Services Administration. National survey on drug use and health, 2014–2020. Available from: SAMHSA.gov/data/data-we-collect/NSDUH-National-Survey-drug-use-and-health. Accessed November 24, 2021.

3. MAGNITUDE OF ALCOHOL-RELATED MORTALITY AND MORBIDITY AMONG U.S. COLLEGE STUDENTS AGES 18–24: Changes from 1998 to 2001

4. National Institutes of Health, National Institute of Drug Abuse. Monitoring the future national survey results on drug use, 1975–2019, volume 1: secondary school students; 2019.

5. Volkow ND. Pandemic worsens opioid crisis: NIDA director; July 2020. Available from: https://drugfree.org/drug-and-alcohol-news/pandemic-worsens-opioid-crisis-NIDA-Director/. Accessed November 24, 2021.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Effects of Psychoactive Drugs;Current Pharmaceutical Design;2023-08

2. Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids;Journal of Personalized Medicine;2022-12-06

3. Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management”;Annals of Translational Medicine;2022-12

4. Why haven't we solved the addiction crisis?;Journal of the Neurological Sciences;2022-11

5. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?;Journal of Personalized Medicine;2022-10-14